Minjie Wei
- Molecular Biology
- Oncology
- Cancer Research
- Radiology, Nuclear Medicine and Imaging
- Pulmonary and Respiratory Medicine
- Topics
- Monoclonal and Polyclonal Antibodies Research (3 papers)CAR-T cell therapy research (2 papers)Antimicrobial Peptides and Activities (2 papers)
- Partner nations
- ChinaUnited KingdomSaint Kitts and Nevis
In The Last Decade
Minjie Wei
13 papers receiving 471 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Molecular Biology 327
- Oncology 132
- Cancer Research 82
- Radiology, Nuclear Medicine and Imaging 57
- Pulmonary and Respiratory Medicine 55
Countries citing papers authored by Minjie Wei
This map shows the geographic impact of Minjie Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjie Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjie Wei more than expected).
Fields of papers citing papers by Minjie Wei
This network shows the impact of papers produced by Minjie Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjie Wei. The network helps show where Minjie Wei may publish in the future.
Co-authorship network of co-authors of Minjie Wei
This figure shows the co-authorship network connecting the top 25 collaborators of Minjie Wei. A scholar is included among the top collaborators of Minjie Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjie Wei. Minjie Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticalsbreakdown → | 33 |
| 2 | 89 | |
| 3 | 20 | |
| 4 | 3 | |
| 5 | 31 | |
| 6 | Recent progress on MHC-I epitope prediction in tumor immunotherapy. | 7 |
| 7 | 4 | |
| 8 | 51 | |
| 9 | 114 | |
| 10 | 36 | |
| 11 | 41 | |
| 12 | 5 | |
| 13 | 40 |
About Minjie Wei
Minjie Wei is a scholar working on Microbiology, Oncology and Sensory Systems, having authored 13 papers that have together received 474 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Antimicrobial Peptides and Activities (2 papers). The work is most often cited by research in Microbiology (38 citations), Cancer Research (82 citations) and Sensory Systems (24 citations). Minjie Wei has collaborated with scholars based in China, United Kingdom and Saint Kitts and Nevis. Frequent co-authors include Lin Zhao, Huizhe Wu, Zhaojin Yu, Jiankun Yu, Qinghuan Xiao, Liang Zou, Ke Ma, Hui Wang, Liwu Fu and Marcia Bellon. Their work appears in journals such as Oncogene, Molecular Cancer and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.